Protocol Ledger

NCT07228104 · Phase III · RECRUITING

Adjuvant Steroid Outcomes in Idiopathic Subglottic Stenosis

Interventional Phase III clinical trial protocol NCT07228104 sponsored by Johns Hopkins University in Rare Genetic, Women's Health, and Other, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2026-05-20 Enrollment: 226 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07228104
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)226 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07228104
Protocol FieldVerified Registry Value
NCT IdentifierNCT07228104
Consolidated Lead SponsorJohns Hopkins University
Therapeutic Condition CohortRare Genetic, Women's Health, and Other
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment226 participants (ESTIMATED)
Registered Start Date2026-05-20
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Johns Hopkins Medicine across sibling Meru public-data platforms.

Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI